Skip to main navigation Skip to search Skip to main content

Oxadiazoles have butyrate-specific conditional activity against mycobacterium tuberculosis

  • Julie V. Early
  • , Allen Casey
  • , Maria Angeles Martinez-Grau
  • , Isabel C.Gonzalez Valcarcel
  • , Michal Vieth
  • , Juliane Ollinger
  • , Mai Ann Bailey
  • , Torey Alling
  • , Megan Files
  • , Yulia Ovechkina
  • , Tanya Parish
  • Infectious Disease Research Institute
  • Eli Lilly
  • TB Discovery Research

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Abstract

Mycobacterium tuberculosis is a global pathogen of huge importance which can adapt to several host niche environments in which carbon source availability is likely to vary. We developed and ran a phenotypic screen using butyrate as the sole carbon source to be more reflective of the host lung environment. We screened a library of ô87,000 small compounds and identified compounds which demonstrated good antitubercular activity against M. tuberculosis grown with butyrate but not with glucose as the carbon source. Among the hits, we identified an oxadiazole series (six compounds) which had specific activity against M. tuberculosis but which lacked cytotoxicity against mammalian cells.

Original languageEnglish
Pages (from-to)3608-3616
Number of pages9
JournalAntimicrobial Agents and Chemotherapy
Volume60
Issue number6
DOIs
Publication statusPublished - 23 Jun 2016
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Oxadiazoles have butyrate-specific conditional activity against mycobacterium tuberculosis'. Together they form a unique fingerprint.

Cite this